Abstract:Objective To evaluate and analyze left atrial function in normal adults of different ages by fullvolume imaging (FVI). Methods A total of 132 healthy adults were divided into three groups according to age, 43 in the youth group, 45 in the middle age group and 44 in the elderly group. Conventional ultrasound was used to measure the diameter lines and area of the left atrium at the end of contraction, and the left atrial volume (LAV) and volume index (LAVI) of the left atrium were calculated. E and A peak were recorded at the mitral orifice, and e and a peaks at the ventricular septal side of the doppler mitral annulus were recorded, and E/A, e/a and E/e were calculated. 3D probe collected four cavity core image, which recorded for each cardiac cycle at diastolic and end-systolic stages of left atrial endometrium, and the system automatically analyzed volume-time curve, recorded left atrium (LAVmax), P wave maximum volume corresponding to the left atrial olume index (LAVpre) and left atrium minimum volume (LAVmin). Left atrial volume index function can be computed parameters and standardized. Results The Mitral blood flow value E/A and tissue doppler value e/a were reduced with age, and the difference was statistically significant (P < 0.05). There was a good correlation between the measured E/A value and the e/a value, the correlation coefficient was 0.746. Compared with the youth group, the measured values of LAVImax, LAVmin, LAVImin, LAVpre and LAVIpre in the middle and old age groups were generally increased, while those of iLAVe, iLAVIe, LApEF, LAItEF and LAIpEF were generally decreased, with statistically significant differences (P < 0.05). There was no statistically significant difference between the middle-aged group and the elderly group (P > 0.05). LAVImax was positively correlated with E/e, and negatively correlated with e/a. Conclusions Real-time three-dimensional FVI technology provides a basis for clinical quantitative evaluation of left atrial volume function and plays an important role in the selection of treatment methods for cardiovascular diseases, the evaluation of treatment effect and the evaluation of prognosis.